Pancreatic cancer-associated inflammation drives dynamic regulation of p35 and Ebi3

Cytokine - Tập 125 - Trang 154817 - 2020
Daniel Michaud1,2, Bhalchandra Mirlekar2, Steven Bischoff3, Dale O. Cowley3, Dario A.A. Vignali4,5, Yuliya Pylayeva-Gupta2,6
1Department of Cell Biology & Physiology, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC 27599, USA
2Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, School of Medicine, Chapel Hill, NC, USA
3UNC Animal Models Core, University of North Carolina, Chapel Hill, NC, USA
4Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA
5Tumor Microenvironment Center, UPMC Hillman Cancer Center, Pittsburgh, PA, USA
6Department of Genetics, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA

Tài liệu tham khảo

Vignali, 2012, IL-12 family cytokines: immunological playmakers, Nat. Immunol., 13, 722, 10.1038/ni.2366 Shen, 2014, IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases, Nature, 507, 366, 10.1038/nature12979 Dambuza, 2017, IL-12p35 induces expansion of IL-10 and IL-35-expressing regulatory B cells and ameliorates autoimmune disease, Nat. Commun., 8, 10.1038/s41467-017-00838-4 Wang, 2014, Interleukin-35 induces regulatory B cells that suppress autoimmune disease, Nat. Med., 20, 633, 10.1038/nm.3554 Sun, 2015, Interleukin 35 may contribute to the loss of immunological self-tolerance in patients with primary immune thrombocytopenia, Br. J. Haematol., 169, 278, 10.1111/bjh.13292 Pylayeva-Gupta, 2016, IL35-producing B cells promote the development of pancreatic neoplasia, Cancer Discov., 6, 247, 10.1158/2159-8290.CD-15-0843 Mirlekar, 2018, IL35 hinders endogenous antitumor T-cell immunity and responsiveness to immunotherapy in pancreatic cancer, Cancer Immunol. Res., 6, 1014, 10.1158/2326-6066.CIR-17-0710 Pylayeva-Gupta, 2016, Molecular pathways: Interleukin-35 in autoimmunity and cancer, Clin. Cancer Res., 22, 4973, 10.1158/1078-0432.CCR-16-0743 Turnis, 2016, Interleukin-35 limits anti-tumor immunity, Immunity, 44, 316, 10.1016/j.immuni.2016.01.013 Lee, 2018, Macrophage-secreted interleukin-35 regulates cancer cell plasticity to facilitate metastatic colonization, Nat. Commun., 9, 10.1038/s41467-018-06268-0 Collison, 2007, The inhibitory cytokine IL-35 contributes to regulatory T-cell function, Nature, 450, 566, 10.1038/nature06306 Collison, 2010, IL-35-mediated induction of a potent regulatory T cell population, Nat. Immunol., 11, 1093, 10.1038/ni.1952 Chehboun, 2017, Epstein-Barr virus-induced gene 3 (EBI3) can mediate IL-6 trans -signaling, J. Biol. Chem., 292, 6644, 10.1074/jbc.M116.762021 Bayne, 2012, Tumor-derived granulocyte-macrophage colony-stimulating factor regulates myeloid inflammation and T cell immunity in pancreatic cancer, Cancer Cell, 21, 822, 10.1016/j.ccr.2012.04.025 Schweighoffer, 2017, TLR4 signals in B lymphocytes are transduced via the B cell antigen receptor and SYK, J. Exp. Med., 214, 1269, 10.1084/jem.20161117 Haxhinasto, 2004, Synergistic B cell activation by CD40 and the B cell antigen receptor: role of B lymphocyte antigen receptor-mediated kinase activation and tumor necrosis factor receptor-associated factor regulation, J. Biol. Chem., 279, 2575, 10.1074/jbc.M310628200 Mizuno, 2005, B cell receptor (BCR) cross-talk: CD40 engagement enhances BCR-induced ERK activation, J Immunol., 174, 3369, 10.4049/jimmunol.174.6.3369 Elgueta, 2009, Molecular mechanism and function of CD40/CD40L engagement in the immune system, Immunol. Rev., 229, 152, 10.1111/j.1600-065X.2009.00782.x Yanaba, 2009, The development and function of regulatory B cells expressing IL-10 (B10 cells) requires antigen receptor diversity and TLR signals, J. Immunol., 182, 7459, 10.4049/jimmunol.0900270 Pone, 2012, BCR-signalling synergizes with TLR-signalling for induction of AID and immunoglobulin class-switching through the non-canonical NF-kappaB pathway, Nat. Commun., 3, 767, 10.1038/ncomms1769 Suthers, 2017, TLR7/TLR9- and B cell receptor-signaling crosstalk: promotion of potentially dangerous B cells, Front. Immunol., 8, 775, 10.3389/fimmu.2017.00775 Kuraoka, 2017, BCR and endosomal TLR signals synergize to increase AID expression and establish central B cell tolerance, Cell Reports, 18, 1627, 10.1016/j.celrep.2017.01.050 Nicholl, 2014, IL-35 promotes pancreas cancer growth through enhancement of proliferation and inhibition of apoptosis: Evidence for a role as an autocrine growth factor, Cytokine, 70, 126, 10.1016/j.cyto.2014.06.020 Huang, 2017, Tumour-derived Interleukin 35 promotes pancreatic ductal adenocarcinoma cell extravasation and metastasis by inducing ICAM1 expression, Nat. Commun., 8 Huang, 2018, Interleukin 35 expression correlates with microvessel density in pancreatic ductal adenocarcinoma, recruits monocytes, and promotes growth and angiogenesis of xenograft tumors in mice, Gastroenterology, 154, 675, 10.1053/j.gastro.2017.09.039